Article
Glucagon-like peptide-1 receptor activation and mental health: a drug-target Mendelian randomization study
2025-02-13
Abstract excerpt
Concerns have been raised about the psychiatric safety of glucagon-like peptide-1 receptor (GLP-1R) agonists, but trial evidence suggests that they ameliorate depressive symptoms. We aimed to assess the associations of GLP-1R activation with mental health well-being and the risk of mental health disorders and substance use disorders. We performed drug-target Mendelian randomization and colocalization analyses usin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 268f1176-6b0e-5567-b918-6639fff757f2
- DOI
- 10.1101/2025.02.12.25322150
